首页> 美国卫生研究院文献>International Journal of Nanomedicine >Development and characterization of p1025-loaded bioadhesive liquid-crystalline system for the prevention of Streptococcus mutans biofilms
【2h】

Development and characterization of p1025-loaded bioadhesive liquid-crystalline system for the prevention of Streptococcus mutans biofilms

机译:预防变形链球菌生物膜的p1025负载生物粘附液晶系统的开发与表征

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Formation of a dental biofilm by Streptococcus mutans can cause dental caries, and remains a costly health problem worldwide. Recently, there has been a growing interest in the use of peptidic drugs, such as peptide p1025, analogous to the fragments 1025–1044 of S. mutans cellular adhesin, responsible for the adhesion and formation of dental biofilm. However, peptides have physicochemical characteristics that may affect their biological action, limiting their clinical performance. Therefore, drug-delivery systems, such as a bioadhesive liquid-crystalline system (LCS), may be attractive strategies for peptide delivery. Potentiation of the action of LCS can be achieved with the use of bioadhesive polymers to prolong their residence on the teeth. In line with this, three formulations – polyoxypropylene-(5)-polyoxyethylene-(20)-cetyl alcohol, oleic acid, and Carbopol C974P in different combinations (F1C, F2C, and F3C) were developed to observe the influence of water in the LCS, with the aim of achieving in situ gelling in the oral environment. These formulations were assessed by polarized light microscopy, small-angle X-ray scattering, rheological analysis, and in vitro bioadhesion analysis. Then, p1025 and a control (chlorhexidine) were incorporated into the aqueous phase of the formulation (F + p1025 and F + chlorhexidine), to determine their antibiofilm effect and toxicity on epithelial cells. Polarized light microscopy and small-angle X-ray scattering showed that F1C and F2C were LCS, whereas F3C was a microemulsion. F1C and F2C showed pseudoplastic behavior and F3C Newtonian behavior. F1C showed the highest elastic and bioadhesive characteristics compared to other formulations. Antibiofilm effects were observed for F + p1025 when applied in the surface-bound salivary phase. The p1025-loaded nanostructured LCS presented limited cytotoxicity and effectively reduced S. mutans biofilm formation, and could be a promising p1025-delivery strategy to prevent the formation of S. mutans dental biofilm.
机译:变形链球菌形成的牙齿生物被膜会引起龋齿,并且仍然是全世界代价高昂的健康问题。最近,人们对使用肽类药物(例如肽p1025)的兴趣与日俱增,类似于变形链球菌细胞粘附素的片段1025–1044,它负责牙齿生物膜的粘附和形成。但是,肽具有可能会影响其生物学作用的理化特性,从而限制了其临床性能。因此,药物递送系统,例如生物粘附液晶系统(LCS),可能是肽递送的有吸引力的策略。通过使用生物粘附性聚合物延长其在牙齿上的停留时间,可以增强LCS的作用。为此,开发了三种配方(聚氧丙烯-(5)-聚氧乙烯-(20)-鲸蜡醇,油酸和Carbopol C974P)以不同的组合(F1C,F2C和F3C)来观察水中的影响。 LCS,目的是在口腔环境中实现原位胶凝。通过偏光显微镜,小角度X射线散射,流变学分析和体外生物粘附分析评估了这些制剂。然后,将p1025和对照(氯己定)掺入制剂的水相(F + p1025和F +氯己定)中,以测定其对上皮细胞的抗生物膜作用和毒性。偏光显微镜和小角X射线散射表明F1C和F2C是LCS,而F3C是微乳液。 F1C和F2C表现出假塑性行为和F3C牛顿行为。与其他配方相比,F1C具有最高的弹性和生物粘附特性。当F + p1025应用于表面结合唾液相时,可观察到抗生物膜作用。载有p1025的纳米结构LCS表现出有限的细胞毒性并有效减少了变形链球菌生物膜的形成,并且可能是一种有希望的p1025递送策略,可防止变形链球菌牙齿生物膜的形成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号